4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044887
See Remarks sold 1,218 shares at $17.99 ($21,912)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bispham Barbara Harlin See Remarks | 2026-06-22 | Sale 10b5-1 | −1,218 | $17.99 | $21,912 | 19,330 | D |
| Open-market sales · 1,218 sh · avg $17.99 · $21,912 | |||||||
Loading xslF345X06/wk-form4_1782245005.xml…